<DOC>
	<DOCNO>NCT01006499</DOCNO>
	<brief_summary>The investigator aim investigate whether adjuvant Pentoxifylline , IgM enrich IVIG Pentoxifylline plus IgM-enriched IVIG reduce mortality Neonatal sepsis .</brief_summary>
	<brief_title>Role 'Pentoxifylline IgM Enriched Intravenous Immunoglobulin Treatment Neonatal Sepsis '</brief_title>
	<detailed_description />
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Immunoglobulins , Intravenous</mesh_term>
	<mesh_term>gamma-Globulins</mesh_term>
	<mesh_term>Rho ( D ) Immune Globulin</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Pentoxifylline</mesh_term>
	<criteria>: All infant thought/diagnosed late early onset sepsis . Pentoxifylline Pentaglobin already give Pentoxifylline Pentaglobin think need contraindicated Major congenital anomaly Intraventricular hemorrhage ( Grade 3 veya 4 ) Congenital infection Inborn error metabolism</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>90 Days</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>neonatal sepsis</keyword>
	<keyword>pentoxyfilline</keyword>
	<keyword>pentaglobin</keyword>
	<keyword>biomarker</keyword>
	<keyword>To reduce mortality neonatal sepsis</keyword>
</DOC>